Inspired by these suggestions of NKG2A+ biases fostering pro-survival anti-cancer TMEs, we gathered spatial transcriptomics samples from five separate patients that comprised three different cancer types: breast, prostate, and ovarian (Figure 4A).64 The gene discussed is KLRC1; the disease is cancer.